CTCFL and breast carcinoma: Besides, BORIS's role in tumor progression was demonstrated through activation of the progesterone and estrogen receptors’ genes promoters11. Moreover, its expression is related to rising stemness traits and epithelial-to-mesenchymal transition (EMT) in breast cancer cells.